Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $INDV vs $OGN | Chartloom

Compare

$INDV vs $OGN

Indivior Pharmaceuticals, Inc · Organon & Co

INDV

Indivior Pharmaceuticals, Inc

OGN

Organon & Co

Compare $INDV vs $OGN

Comparing Indivior Pharmaceuticals, Inc and Organon & Co

INDVIndivior Pharmaceuticals, Inc

OGNOrganon & Co

INDVIndivior Pharmaceuticals, Inc

Market cap

$4.29B

P/E (TTM)

12.37x

Forward P/E (NTM)

7.50x

Forward P/S (NTM)

3.13x

Rev growth (TTM)

13.6%

YTD performance

-0.9%

52W performance

48.9%

FCF yield

-2.5%

OGNOrganon & Co

Market cap

$3.62B

P/E (TTM)

17.82x

Forward P/E (NTM)

3.84x

Forward P/S (NTM)

0.58x

Rev growth (TTM)

-2.5%

YTD performance

90.2%

52W performance

43.4%

FCF yield

12.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INDV

OGN

Detailed metrics comparison

INDV

Indivior Pharmaceuticals, Inc

OGN

Organon & Co

Market Cap

INDV$4.29B

OGN$3.62B

Enterprise Value

INDV$4.55B

OGN$11.04B

Price

INDV$35.42

OGN$13.77

P/E Ratio

INDV12.37x

OGN17.82x

P/S Ratio

INDV3.22x

OGN0.59x

EV/Sales

INDV3.42x

OGN1.80x

EV/EBITDA

INDV10.26x

OGN6.50x

P/B Ratio

INDV422.91x

OGN3.61x

P/FCF Ratio

INDVN/A

OGN8.33x

EV/FCF

INDV-41.75x

OGN25.43x

PEG Ratio

INDV0.41x

OGNN/A

Forward P/E (NTM)

INDV7.50x

OGN3.84x

Forward P/S (NTM)

INDV3.13x

OGN0.58x

Revenue (TTM)

INDV$1.33B

OGN$6.13B

Revenue Growth (YoY)

INDV13.6%

OGN-2.5%

Forward Rev Growth

INDV5.4%

OGN1.6%

Gross Margin (TTM)

INDV82.0%

OGN52.7%

Operating Margin (TTM)

INDV30.3%

OGN8.0%

EBITDA Margin (TTM)

INDV33.1%

OGN27.7%

Net Margin (TTM)

INDV26.7%

OGN3.4%

FCF Margin (TTM)

INDV-8.2%

OGN7.1%

Net Income (TTM)

INDV$355M

OGN$209M

FCF (TTM)

INDV$-109M

OGN$434M

EPS (TTM)

INDV$2.86

OGN$0.77

ROE (TTM)

INDV159.1%

OGN23.4%

ROA (TTM)

INDV28.1%

OGN1.6%

ROIC (TTM)

INDV29.4%

OGN2.2%

Cash

INDV$222M

OGN$1.13B

Debt

INDV$487M

OGN$8.55B

Net Cash/Debt

INDV$-265M

OGN$-7.42B

Current Ratio (TTM)

INDV0.84x

OGN1.95x

Quick Ratio (TTM)

INDV0.65x

OGN1.44x

Debt/Equity (TTM)

INDV27.90x

OGN8.50x

Debt/Assets (TTM)

INDV0.0%

OGN0.0%

Interest Coverage (TTM)

INDVN/A

OGNN/A

Net Debt/EBITDA (TTM)

INDV0.00x

OGN0.00x

Beta

INDV0.49

OGN1.50

52W Performance

INDV48.9%

OGN43.4%

YTD Performance

INDV-0.9%

OGN90.2%

% from 52W High

INDV-17.3%

OGN-0.7%

% from 52W Low

INDV50.4%

OGN142.0%

Asset Turnover (TTM)

INDV1.06x

OGN0.47x

FCF Yield (TTM)

INDV-2.5%

OGN12.0%

Earnings Yield (TTM)

INDV8.3%

OGN5.8%

Dividend Yield (TTM)

INDVN/A

OGN0.5%

Rule of 40

INDV5.4

OGN4.6

EV/GP/RG

INDV1.40

OGN2.99

Ticker research

View INDV research View OGN research

Metric	INDV Indivior Pharmaceuticals, Inc	OGN Organon & Co
Market & Valuation
Market Cap	$4.29B	$3.62B
Enterprise Value	$4.55B	$11.04B
Price	$35.42	$13.77
P/E Ratio	12.37x	17.82x
P/S Ratio	3.22x	0.59x
EV/Sales	3.42x	1.80x
EV/EBITDA	10.26x	6.50x
P/B Ratio	422.91x	3.61x
P/FCF Ratio	N/A	8.33x
EV/FCF	-41.75x	25.43x
PEG Ratio	0.41x	N/A
Forward P/E (NTM)	7.50x	3.84x
Forward P/S (NTM)	3.13x	0.58x
Revenue & Growth
Revenue (TTM)	$1.33B	$6.13B
Revenue Growth (YoY)	13.6%	-2.5%
Forward Rev Growth	5.4%	1.6%
Profitability
Gross Margin (TTM)	82.0%	52.7%
Operating Margin (TTM)	30.3%	8.0%
EBITDA Margin (TTM)	33.1%	27.7%
Net Margin (TTM)	26.7%	3.4%
FCF Margin (TTM)	-8.2%	7.1%
Net Income (TTM)	$355M	$209M
FCF (TTM)	$-109M	$434M
EPS (TTM)	$2.86	$0.77
ROE (TTM)	159.1%	23.4%
ROA (TTM)	28.1%	1.6%
ROIC (TTM)	29.4%	2.2%
Financial Health
Cash	$222M	$1.13B
Debt	$487M	$8.55B
Net Cash/Debt	$-265M	$-7.42B
Current Ratio (TTM)	0.84x	1.95x
Quick Ratio (TTM)	0.65x	1.44x
Debt/Equity (TTM)	27.90x	8.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.50
52W Performance	48.9%	43.4%
YTD Performance	-0.9%	90.2%
% from 52W High	-17.3%	-0.7%
% from 52W Low	50.4%	142.0%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.47x
FCF Yield (TTM)	-2.5%	12.0%
Earnings Yield (TTM)	8.3%	5.8%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	5.4	4.6
EV/GP/RG	1.40	2.99
Ticker research	View INDV research	View OGN research

Valuation

P/E Ratio

INDV

12.37x

OGN

17.82x

P/S Ratio

OGN

0.59x

INDV

3.22x

EV/FCF

INDV

-41.75x

OGN

25.43x

Growth & revenue

Revenue Growth TTM

INDV

13.6%

OGN

-2.5%

Forward Revenue Growth

INDV

5.4%

OGN

1.6%

Profitability & performance

Gross Margin

INDV

82.0%

OGN

52.7%

ROE

INDV

159.1%

OGN

23.4%

FCF Yield %

OGN

12.0%

INDV

-2.5%

52-Week Performance

INDV

48.9%

OGN

43.4%

Detailed metrics comparison

INDV

Indivior Pharmaceuticals, Inc

OGN

Organon & Co

Market Cap

INDV$4.29B

OGN$3.62B

Enterprise Value

INDV$4.55B

OGN$11.04B

Price

INDV$35.42

OGN$13.77

P/E Ratio

INDV12.37x

OGN17.82x

P/S Ratio

INDV3.22x

OGN0.59x

EV/Sales

INDV3.42x

OGN1.80x

EV/EBITDA

INDV10.26x

OGN6.50x

P/B Ratio

INDV422.91x

OGN3.61x

P/FCF Ratio

INDVN/A

OGN8.33x

EV/FCF

INDV-41.75x

OGN25.43x

PEG Ratio

INDV0.41x

OGNN/A

Forward P/E (NTM)

INDV7.50x

OGN3.84x

Forward P/S (NTM)

INDV3.13x

OGN0.58x

Revenue (TTM)

INDV$1.33B

OGN$6.13B

Revenue Growth (YoY)

INDV13.6%

OGN-2.5%

Forward Rev Growth

INDV5.4%

OGN1.6%

Gross Margin (TTM)

INDV82.0%

OGN52.7%

Operating Margin (TTM)

INDV30.3%

OGN8.0%

EBITDA Margin (TTM)

INDV33.1%

OGN27.7%

Net Margin (TTM)

INDV26.7%

OGN3.4%

FCF Margin (TTM)

INDV-8.2%

OGN7.1%

Net Income (TTM)

INDV$355M

OGN$209M

FCF (TTM)

INDV$-109M

OGN$434M

EPS (TTM)

INDV$2.86

OGN$0.77

ROE (TTM)

INDV159.1%

OGN23.4%

ROA (TTM)

INDV28.1%

OGN1.6%

ROIC (TTM)

INDV29.4%

OGN2.2%

Cash

INDV$222M

OGN$1.13B

Debt

INDV$487M

OGN$8.55B

Net Cash/Debt

INDV$-265M

OGN$-7.42B

Current Ratio (TTM)

INDV0.84x

OGN1.95x

Quick Ratio (TTM)

INDV0.65x

OGN1.44x

Debt/Equity (TTM)

INDV27.90x

OGN8.50x

Debt/Assets (TTM)

INDV0.0%

OGN0.0%

Interest Coverage (TTM)

INDVN/A

OGNN/A

Net Debt/EBITDA (TTM)

INDV0.00x

OGN0.00x

Beta

INDV0.49

OGN1.50

52W Performance

INDV48.9%

OGN43.4%

YTD Performance

INDV-0.9%

OGN90.2%

% from 52W High

INDV-17.3%

OGN-0.7%

% from 52W Low

INDV50.4%

OGN142.0%

Asset Turnover (TTM)

INDV1.06x

OGN0.47x

FCF Yield (TTM)

INDV-2.5%

OGN12.0%

Earnings Yield (TTM)

INDV8.3%

OGN5.8%

Dividend Yield (TTM)

INDVN/A

OGN0.5%

Rule of 40

INDV5.4

OGN4.6

EV/GP/RG

INDV1.40

OGN2.99

Ticker research

View INDV research View OGN research

Metric	INDV Indivior Pharmaceuticals, Inc	OGN Organon & Co
Market & Valuation
Market Cap	$4.29B	$3.62B
Enterprise Value	$4.55B	$11.04B
Price	$35.42	$13.77
P/E Ratio	12.37x	17.82x
P/S Ratio	3.22x	0.59x
EV/Sales	3.42x	1.80x
EV/EBITDA	10.26x	6.50x
P/B Ratio	422.91x	3.61x
P/FCF Ratio	N/A	8.33x
EV/FCF	-41.75x	25.43x
PEG Ratio	0.41x	N/A
Forward P/E (NTM)	7.50x	3.84x
Forward P/S (NTM)	3.13x	0.58x
Revenue & Growth
Revenue (TTM)	$1.33B	$6.13B
Revenue Growth (YoY)	13.6%	-2.5%
Forward Rev Growth	5.4%	1.6%
Profitability
Gross Margin (TTM)	82.0%	52.7%
Operating Margin (TTM)	30.3%	8.0%
EBITDA Margin (TTM)	33.1%	27.7%
Net Margin (TTM)	26.7%	3.4%
FCF Margin (TTM)	-8.2%	7.1%
Net Income (TTM)	$355M	$209M
FCF (TTM)	$-109M	$434M
EPS (TTM)	$2.86	$0.77
ROE (TTM)	159.1%	23.4%
ROA (TTM)	28.1%	1.6%
ROIC (TTM)	29.4%	2.2%
Financial Health
Cash	$222M	$1.13B
Debt	$487M	$8.55B
Net Cash/Debt	$-265M	$-7.42B
Current Ratio (TTM)	0.84x	1.95x
Quick Ratio (TTM)	0.65x	1.44x
Debt/Equity (TTM)	27.90x	8.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.50
52W Performance	48.9%	43.4%
YTD Performance	-0.9%	90.2%
% from 52W High	-17.3%	-0.7%
% from 52W Low	50.4%	142.0%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.47x
FCF Yield (TTM)	-2.5%	12.0%
Earnings Yield (TTM)	8.3%	5.8%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	5.4	4.6
EV/GP/RG	1.40	2.99
Ticker research	View INDV research	View OGN research